The Venture Codex Logo

The Venture Codex

AN Ventures

3739 Balboa Street, Unit 5011, San Francisco, California, 94121, United States

Overview

Global biotech venture capital fund maximizing value creation.

Founded

2022

Deals ยท 12mo

4

Links

WebsiteLinkedIn

Stage focus

Seed
Series A
Series B

Geographic focus

United States

Sector focus

Biotechnology
Finance
Financial Services
Life Science
...

Investment portfolio

9rounds
NAMEDATESIZE
Typewriter Therapeutics
Sep 2026Led
$56 MSeries A
Crystalys Therapeutics
Jul 2026Participated
$130 MSeries B
City Therapeutics
Jun 2026Participated
$100 MSeries B
Tortugas Neuroscience
Apr 2026Participated
$106 MSeed
Crystalys Therapeutics
Sep 2025Participated
$205 MSeries A
Pahr Therapeutics
Jul 2025Led
$14 MSeed
Imbria Pharmaceuticals
Apr 2025Participated
$58 MSeries B
City Therapeutics
Oct 2024Participated
$135 MSeries A
Typewriter Therapeutics
Feb 2024Led
$5 MSeed
Typewriter Therapeutics
Sep 2026Led
$56 MSeries A
Crystalys Therapeutics
Jul 2026Participated
$130 MSeries B
City Therapeutics
Jun 2026Participated
$100 MSeries B
Tortugas Neuroscience
Apr 2026Participated
$106 MSeed
Crystalys Therapeutics
Sep 2025Participated
$205 MSeries A
Pahr Therapeutics
Jul 2025Led
$14 MSeed
Imbria Pharmaceuticals
Apr 2025Participated
$58 MSeries B
City Therapeutics
Oct 2024Participated
$135 MSeries A
Typewriter Therapeutics
Feb 2024Led
$5 MSeed
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

AN Ventures: 9 funding rounds are recorded in the selected participation categories.All available history.
AN Ventures: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed21
Series A12
Series B03

Monthly Deal Activity

AN Ventures: 9 deals are recorded across 33 months.All available history.
AN Ventures: 9 deals are recorded across 33 months. All available history
MonthDeals
Feb '241
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '251
May '250
Jun '250
Jul '251
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '261
Jul '261
Aug '260
Sep '261
Oct '260

Sector Breakdown

AN Ventures: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

AN Ventures: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Space & Frontier Tech1

Deal Size Distribution

AN Ventures: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

AN Ventures: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M1
$25M-$50M0
$50M-$100M3
$100M-$250M4
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

AN Ventures: United States has the largest recorded deal count among the displayed regions (9 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

AN Ventures: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
RegionDeals
United States9
AN Ventures: 20 co-investors are shown, with RA Capital Management sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

AN Ventures: 20 co-investors are shown, with RA Capital Management sharing 4 recorded deals. All available history
Co-investorShared deals
RA Capital Management4
abrdn2
Alexandria Venture Investments2
ANRI2
ARCH Venture Partners2
Catalys Pacific2
Fidelity Management & Research Company2
Invus2
KB Investment2
Lightstone Ventures2
Longwood Fund2
Novo Holdings2
Perceptive Xontogeny Venture Fund2
Pontifax2
Prebys Ventures Fund2
Regeneron Ventures2
Rock Springs Capital2
Slate Path Capital2
SR One2
Wedbush Healthcare Partners2

Investment Strategy

AN Ventures: Led accounts for 33% and participating for 67% of round participation.All available history.
AN Ventures: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led333%
Participating667%
AN Ventures: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
AN Ventures: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led3100%

Team

Ken Horne